Multiple Sclerosis Therapeutics Market Worth US$ 39,223.59 million by 2027
                     Multiple Sclerosis Therapeutics Market 
Multiple Sclerosis Therapeutics Market 
Forecast to 2027 - COVID-19 Impact and 
Global Analysis By Drug Class 
(Immunosuppressant and 
Immunomodulators), Route of 
Administration (Injectable and Oral), and 
Distribution Channel (Hospital Pharmacies, 
Retail Pharmacies, and E-Commerce), and 
Geography
Multiple Sclerosis Therapeutics Market 
Current and future Market Scenario
The Multiple Sclerosis Therapeutics Market was 
valued at US$ 24,026.90 million in 2019 and it is 
projected to reach US$ 39,223.59 million by 
2027; it is expected to grow at a CAGR of 6.5% 
from 2020 to 2027.
•Food Service
•Food Retail
Multiple Sclerosis Therapeutics Market 
 
Market Segments
By Drug Class By Route of Administration By Distribution Channel
Immunosuppressant Injectable Hospital Pharmacies
Immunomodulators Retail PharmaciesOral 
Others E-CommerceOthers
Others
Multiple Sclerosis Therapeutics Market  
Leading Players
Company Profiles in Multiple Sclerosis Therapeutics Market are:
Merck & Co., Inc.             
Novartis AG         
Bayer AG             
Sanofi     
Bristol-Myers Squibb Company     
Horizon Therapeutics plc.              
TEVA PHARMACEUTICAL INDUSTRIES LTD         
Takeda Pharmaceutical Company Limited              
F. HOFFMANN-LA ROCHE LTD.    
Biogen
 
 Multiple Sclerosis Therapeutics Market
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/multiple-sclerosis-therapeutics-market 
 
Thank You! 
Thank You!